Compounding Pharmacy Website Compliance: 503A, 503B, and HIPAA Explained

A standard pharmacy website may primarily present services, locations, products, and contact information.

A compounding pharmacy can have an additional layer of complexity because the website may describe compounded preparations, support prescription workflows, collect patient information, and connect to external healthcare systems.

That creates two different questions. First, does the content and ordering process reflect the pharmacy's applicable compounding designation? Second, does the website handle protected health information in a HIPAA-compliant manner?

For organisations reviewing their broader digital architecture, our pharmacy platform development services address the technical side of prescription workflows, integrations, and patient-facing functionality.

Consider a refill page that allows a patient to select a compounded medication, upload a prescription, provide identifying information, and submit the request.

The product and ordering process can raise questions under the applicable compounding framework. The submitted patient information creates a separate HIPAA consideration.

These obligations should not be treated as one compliance requirement.

FDA rules determine what the pharmacy can lawfully compound and distribute under its applicable designation. HIPAA governs how covered entities and business associates handle protected health information.

A single page can therefore require both regulatory and technical review.

Generic pharmacy website guidance often focuses on common issues such as contact information, product presentation, accessibility, privacy notices, and basic security.

Those topics remain relevant, but they do not answer the questions specific to compounded medications.

Your development team needs to know whether the pharmacy operates under 503A, 503B, or both. It also needs to understand whether a particular workflow represents a patient-specific prescription process, office-use distribution process, refill request, or another transaction.

During healthcare implementations, we have separated 503A and 503B product content on pharmacy websites so ordering flows matched the applicable prescription requirements.

The practical lesson is to define the regulatory workflow before designing the interface.

The distinction between 503A and 503B matters because the 2 frameworks support different compounding and distribution models.

Your website should not assume that one product presentation or ordering flow works for both.

The distinction should appear in your content model, product data, prescription workflow, and administrative controls where both designations operate.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounded drug products are tied to patient-specific prescriptions indicating that the compounded drug is clinically necessary compared with an approved alternative.

That requirement has direct implications for website architecture.

A 503A pharmacy should not design its product catalogue as though every compounded formulation were simply a generally available retail product. The ordering workflow needs to reflect the prescription requirement.

Product pages can provide appropriate information about services and formulations, but the transaction flow should distinguish information about a compounded preparation from the process through which a patient-specific prescription is received and fulfilled.

The FDA's guidance, Pharmacy Compounding of Human Drug Products Under Section 503A, provides the relevant federal framework.

The current legal position also requires care around advertising language. Historic 503A advertising restrictions were challenged in Thompson v. Western States Medical Center, and the 2013 Compounding Quality Act removed the invalidated provisions from the statute.

The practical concern today is therefore not a standalone prohibition on advertising compounded medications. Your content and ordering process still need to reflect the applicable prescription and compounding requirements, including the "essentially a copy" limitation.

Section 503B applies to outsourcing facilities operating under that framework.

Unlike 503A pharmacies, 503B outsourcing facilities may compound and distribute larger batches of drug products for office use without requiring a patient-specific prescription.

That distinction changes how a website should communicate ordering.

A 503B website may need a different workflow for institutional or professional customers compared with a 503A patient-facing prescription process. Treating both as the same ecommerce journey can create confusion about who is ordering, for whom, and under what regulatory framework.

The R Street Institute's discussion of compounding pharmacies and compounded medications, referencing FDA guidance, describes this distinction between 503A and 503B operations.

If your organisation operates under both designations, separate the applicable product and ordering logic rather than relying on a single generic product template.

The "essentially a copy" restriction matters because website content can influence how a compounded preparation is described and positioned.

Your content team should avoid language that makes a compounded preparation appear interchangeable with an approved drug without considering the applicable regulatory requirements.

Product descriptions should therefore be reviewed as part of the pharmacy's compliance process, not treated solely as marketing copy.

A useful implementation approach is to connect each product record with its applicable designation, prescription requirement, intended ordering pathway, and review status.

That creates a clearer control point when content changes later.

A pharmacy website becomes a different technical environment when patients submit identifiable prescription or health information.

A refill request may include a patient's name, contact details, medication information, prescription information, and other data connected to healthcare services.

The pharmacy therefore needs to assess the form and its supporting infrastructure under HIPAA rather than treating it as an ordinary website contact form.

Protected Health Information includes individually identifiable health information handled by a covered entity or business associate in the context covered by HIPAA.

A refill request can contain information that identifies a patient and relates to their medication or healthcare service.

The practical point is that the risk begins with the data flow, not with the database.

Information can pass through the browser, web server, form processor, email system, analytics tools, CRM, storage service, or third-party integration before reaching the pharmacy's primary system.

Your technical review should map that complete journey.

According to DialogHealth's reporting of HIPAA enforcement statistics, 55% of HIPAA financial penalties are imposed on small medical practices. For independently operated pharmacies, that is a useful reminder that organisational size does not remove the need for appropriate safeguards.

Prescription uploads introduce additional technical considerations because the submitted document can contain sensitive patient and prescription information.

A secure implementation should address encryption in transit and appropriate protection at rest. Access controls should also ensure that only authorised users can retrieve submitted documents.

The system should define who can access an uploaded prescription, what roles can download it, how access is logged, and how long the document should remain available.

Across recent compliance projects, we have reviewed prescription upload encryption and access control before a compounding pharmacy client's launch.

For a wider implementation framework, see our HIPAA compliant website development services.

The minimum necessary standard is particularly relevant to pharmacy forms.

A refill request should not automatically ask for every piece of clinical information that the pharmacy could potentially collect. Each field should have a defined operational purpose.

For example, a form may need information required to identify the patient, prescription, pharmacy account, and requested service. Additional clinical questions should have a clear reason for collection.

Our guide to HIPAA compliant contact forms covers the broader principles that apply when healthcare websites collect patient information through web forms.

A useful implementation control is to review every form field during development and document why the pharmacy needs it.

Federal compounding rules and HIPAA do not represent the complete compliance picture.

Pharmacies also operate within state regulatory frameworks. State boards of pharmacy can impose requirements that affect how the organisation presents its licence, contact details, disclosures, and services online.

A pharmacy serving patients or customers across multiple states may face different state-level requirements.

That makes a single national website template risky when it assumes every jurisdiction requires the same information.

Your website architecture should support state-specific content where necessary. Licence details, disclosures, pharmacy information, and other regulated content should be managed so updates can occur without rebuilding the entire site.

The exact requirements depend on the jurisdiction and pharmacy's activities.

Website governance should therefore include a documented review of the applicable state board requirements rather than relying on a generic pharmacy template.

Where a state requires specific pharmacy information to appear publicly, that information should have a clear content owner and review process.

For multi-state pharmacies, structured fields can make this easier to maintain. A central pharmacy profile can hold jurisdiction-specific licence information while keeping patient-facing content consistent where appropriate.

The most difficult website compliance problems often occur where multiple requirements overlap.

A product page may need FDA-related review. A refill form may require HIPAA safeguards. A pharmacy location page may need state-specific information.

Those requirements should be mapped to individual website components.

RxHere provides a useful example of why pharmacy workflows need this level of technical separation. Its platform involved multi-state order handling, provider credentialing, payment enforcement, ShipStation integration, BestRx integration, and HIPAA audit logging.

The implementation lesson is to treat compliance requirements as part of the system architecture rather than a collection of disconnected website notices.

Third-party integrations can create another compliance boundary.

An e-prescribing service may process or transmit patient information on behalf of the pharmacy. Other systems may handle payments, shipping, prescription management, customer communication, analytics, or clinical workflows.

Each connection needs to be assessed based on the information it receives and the services it performs.

DoseSpot can be integrated into healthcare platforms to support e-prescribing workflows.

The important issue for your pharmacy is not simply whether an integration works technically. You also need to understand what information flows through it, which organisation controls the information, and what contractual safeguards apply.

Integration documentation should identify the data exchanged, system responsibilities, authentication method, error handling, and relevant audit requirements.

A technical integration should not move into production solely because the API connection has passed testing.

Where HIPAA requires a business associate relationship, the relevant parties need appropriate contractual arrangements.

That can include third-party vendors that handle PHI on the pharmacy's behalf.

A BAA should be assessed based on the actual relationship and services involved. It should not be assumed that a pharmacy's agreement with one vendor automatically covers another vendor in the technology chain.

Based on our healthcare IT experience, we have confirmed that a signed BAA existed with an e-prescribing vendor before the integration went live on a client's refill workflow.

For the broader framework, see the HIPAA compliance overview when mapping vendor relationships and safeguards.

A pharmacy can have a well-protected website and still create a compliance gap through an external service.

For example, the website may encrypt a prescription upload correctly while sending related information to another system that has not been assessed appropriately.

The same issue can occur with email notifications, analytics, CRM systems, payment workflows, or third-party form processors.

Your vendor inventory should therefore include every service that touches patient information. Each service should have an identified purpose, data flow, security assessment, and contractual status.

Use the following checklist before launching a new website, refill workflow, or pharmacy platform.

Qrolic Health works on pharmacy platforms where prescription workflows, external integrations, protected health information, and operational requirements need to function together.

The practical objective is to make compliance requirements visible in the architecture, content model, vendor chain, and testing process.

Compounding pharmacy website compliance sits at the intersection of FDA compounding requirements, HIPAA, state pharmacy rules, and third-party technology.

The first step is identifying whether each workflow falls under 503A, 503B, or another applicable framework. From there, your team can design product content, prescription workflows, refill forms, uploads, and integrations around the correct requirements.

HIPAA adds a separate technical layer whenever the website handles protected health information. Encryption, access control, minimum necessary collection, vendor assessment, and BAAs should therefore be considered alongside the website's functional requirements.

For an independently operated compounding pharmacy, the practical objective is clear. Build the regulatory requirements into the website architecture before patient data and prescription workflows reach production.